Table 1.
Existing animal models for aaRS-induced CMT through dominant mutations
| Gene/CMT subtype | Animal | Mutation | Genetic manipulation | Phenotype severity | Refs. |
|---|---|---|---|---|---|
| GARS/CMT2D | Mouse | C157R | Knockin | P234KY > C157R | 61 |
| P234KY | Knockin | 60 | |||
| Drosophila | E71G | Transgenic overexpression | P234KY > G240R > G526R > E71G | 41 | |
| P234KY | Transgenic overexpression | 64 | |||
| G240R | Transgenic overexpression | 41, 64 | |||
| G526R | Transgenic overexpression | 41 | |||
| YARS/DI-CMTC | Drosophila | G41R | Transgenic overexpression | E196K > G41R > Δ153–156 | 40 |
| Δ153–156 | Transgenic overexpression | 40 | |||
| E196K | Transgenic overexpression | 40 | |||
| AARS/CMT2N | Zebrafish | R326W | mRNA injection of embryos | Varies among experiments | 27 |
| E337K | mRNA injection of embryos | 27 | |||
| S627L | mRNA injection of embryos | 27 | |||
| HARS/CMT2W | C. elegans | R137Q | Transgenic overexpression | Not reported | 44 |
| D364Y | Transgenic overexpression | 42 |